Pharm D Notes 📝📒

Here are some useful tools for producing a Research or Review Article 👇👇👇
1.Quill bot for paraphrase
Grammarly for grammar corrections
2.HIX bypass to humanise
Zerogpt for AI dectection
3.Plagiarism detector.net for plagiarism check
4.Humbot.ai to humanise AI generated content

JNTUA RC, CV & PCA Notification for Pharm.D II, III, IV Year (R17, R14) Regular & Supplementary Examinations Results - July/August/September 2024 @ https://www.forum.universityupdates.in/threads/jntua-rc-cv-pca-notification-for-pharm-d-ii-iii-iv-year-r17-r14-regular-supplementary-examinations-results-july-august-september-2024.49365/

JNTUA Pharm.D II, III, IV Year (R17, R14) Regular & Supplementary Examinations Results - July/August/September 2024 @ https://www.forum.universityupdates.in/threads/jntua-pharm-d-ii-iii-iv-year-r17-r14-regular-supplementary-examinations-results-july-august-september-2024.49349/

Andhra Pradesh Pharmacy Council is shifting to Vijayawada (Address: Regional Drug store building, First floor, Siddhartha Medical College Compound, NH 16 service road, Gunadala, Vijayawada, NTR District - 520008.)

Hence those who have booked the slot dates from 01.11.024 to 08.11.2024 are requested to come to the office between 12.11.2024 to 12.12.2024 on any working day during office hours for verification of certificates and documents at Andhra Pradesh Pharmacy Council, office, Regional Drug store building, 1st floor, Siddhartha Medical College Compound, NH 16 Service Road, Gunadala, Vijayawada, NTR District - 520008.

With Regards,
Registrar,
A.P.Pharmacy Council
Guntur.
Phone:08632224524.

Several notable drugs have been recently approved in 2024, bringing advancements in treatments across various conditions. Key updates include:

1. Cobenfy (xanomeline and trospium chloride), approved for schizophrenia, being a first-in-class muscarinic agonist.
2. Aqneursa (levacetylleucine), for Niemann-Pick disease type C.
3. Ebglyss (lebrikizumab-lbkz), an IL-13 inhibitor for moderate-to-severe atopic dermatitis.
4. Tecentriq Hybreza (atezolizumab and hyaluronidase), a cancer immunotherapy targeting PD-L1 for lung cancer, melanoma.

*Join Us for Another Exciting Webinar!*

ClinoSol Research, in collaboration with the Indian Pharmaceutical Association and the Indian Pharmaceutical Association Students' Forum, invites you to join our upcoming webinar!

*Topic: "Adoption and Impact of Technology on Clinical Operations"*

📅 Date: 26th October 2024
🕕 Time: 6:00 PM (IST)

🎙️ Expert Speakers:

Dr. Siew Lee Goh – Director, Patient Recruitment & Retention Management, Syneos Health, Singapore
Abhishek Tyagi – Senior Director, FSP Hub Lead India
Suhail Ali – Vice President & Head, Clinical Delivery APAC, ICON
Dr. Sridhar Yeshamaina – Artificial Intelligence Scientist, Boston University, USA
Mujeebuddin Shaik – Founder & CEO, ClinoSol Research

*Free Registration + Participation Certificate*

📝 Register Now: https://forms.gle/74K8fMrAnp3GxKoj9
💬 Join the WhatsApp Group: https://chat.whatsapp.com/KWTsOn33YMvJsIJsEUuZ8O

Don’t miss this opportunity to gain insights from industry experts on how technology is transforming clinical operations. See you there!

Best Regards,
Team ClinoSol

https://webjapps.ias.ac.in/fellowship2025/application_instructions.jsp

JNTUA Pharm D 2nd year Question papers September 2024 Regular and supplementary